Clinical Trial Update: Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated armodafinil for excessive sleepiness in healthy subjects with jet lag disorder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excessive Daytime Sleepiness
• Jet Lag Disorder

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: Cephalon | Conditions: Excessive Sleepiness | Phase 3 | Status: COMPLETED | Results posted: 2010-07-08